Literature DB >> 19481720

Oral contraceptive effectiveness according to body mass index, weight, age, and other factors.

Jürgen C Dinger1, Maureen Cronin, Sabine Möhner, Ilka Schellschmidt, Thai Do Minh, Carolyn Westhoff.   

Abstract

OBJECTIVE: The purpose of this study was to assess the use-effectiveness of oral contraceptives (OCs) in Europe according to body mass index (BMI), weight, age, and other factors. STUDY
DESIGN: In a planned secondary analysis, we used data from the European Active Surveillance Study on Oral Contraceptives, which was a prospective active cohort surveillance study of 59,510 OC users, to assess the effectiveness of OCs overall and by BMI, weight, age, duration of use, ethinylestradiol dose, regimen type, starting/switching status, and parity. Self-reported unplanned pregnancies during OC use were confirmed by interview.
RESULTS: An analysis of OC effectiveness (112,659 women-years of exposure and 545 unplanned pregnancies) found little variation in effectiveness by BMI/weight. Failure rates decreased after 30 years of age and with an increasing duration of use.
CONCLUSION: OC users in Europe reported high contraceptive effectiveness with "typical use." Failure rates decreased with age and duration of use. BMI and weight had little, if any, influence on effectiveness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481720     DOI: 10.1016/j.ajog.2009.03.017

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.

Authors:  Carolyn L Westhoff; Anupama H Torgal; Elizabeth Rose Mayeda; Kelsey Petrie; Tiffany Thomas; Monica Dragoman; Serge Cremers
Journal:  Am J Obstet Gynecol       Date:  2012-04-28       Impact factor: 8.661

Review 2.  Contraception and the obese woman.

Authors:  Elizabeth Reifsnider; Nonie Mendias; Yolanda Davila; Jennie Bever Babendure
Journal:  J Am Assoc Nurse Pract       Date:  2013-02-27       Impact factor: 1.165

3.  Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women.

Authors:  Carolyn L Westhoff; Anupama H Torgal; Elizabeth R Mayeda; Malcolm C Pike; Frank Z Stanczyk
Journal:  Contraception       Date:  2010-02-20       Impact factor: 3.375

4.  Hormonal contraception--what kind, when, and for whom?

Authors:  Inka Wiegratz; Christian J Thaler
Journal:  Dtsch Arztebl Int       Date:  2011-07-18       Impact factor: 5.594

Review 5.  A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive.

Authors:  Nattawut Leelakanok; Janthima Methaneethorn
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

Review 6.  Obesity and contraception.

Authors:  Sheila K Mody; Michelle Han
Journal:  Clin Obstet Gynecol       Date:  2014-09       Impact factor: 2.190

7.  Class III obesity and unwanted pregnancy among women with live births in New York City, 2004-2007.

Authors:  Samantha Garbers; Mary Ann Chiasson
Journal:  Matern Child Health J       Date:  2013-10

Review 8.  Obesity and hormonal contraceptive efficacy.

Authors:  Jennifer A Robinson; Anne E Burke
Journal:  Womens Health (Lond)       Date:  2013-09

Review 9.  Safety and efficacy of contraception--Why should the obese woman be any different?

Authors:  Maria I Rodriguez; Alison B Edelman
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

10.  Altered pharmacokinetics of combined oral contraceptives in obesity - multistudy assessment.

Authors:  Dandan Luo; Carolyn L Westhoff; Alison B Edelman; Melissa Natavio; Frank Z Stanczyk; William J Jusko
Journal:  Contraception       Date:  2019-01-23       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.